Litigation Details for Almirall, LLC v. Amneal Pharmaceuticals LLC (D. Del. 2019)
✉ Email this page to a colleague
Almirall, LLC v. Amneal Pharmaceuticals LLC (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-04-09 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 9,517,219 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Almirall, LLC v. Amneal Pharmaceuticals LLC
Details for Almirall, LLC v. Amneal Pharmaceuticals LLC (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-01-24 | 167 | Order - -Memorandum and Order | Almirall sued Amneal in 2019, asserting U.S. Patent No. 9,517,219 in an attempt to stop Amneal from obtaining… I Almirall owns U.S. Patent No. 9,517,219, which covers ACZONE (dapsone) Gel, 7.5%…language of the claims of patent, the patent’s specification and the patent’s prosecution history (i.…the ’219 patent and the patent at issue in Geneva Pharms—infringement of the ’219 patent does not … A “[A] patent claim is that ‘portion of the patent document that defines the scope | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |